Zellweger et al hypothesised that upregulation of this protein can represent an adaptive cell-survival mechanism on the basis of their previous observation that clusterin is overexpressed in prostate cancer (Miyake et al, 2000). The gene discussed is CLU; the disease is prostate carcinoma.